{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:50:53Z","timestamp":1760122253633},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathophysiology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.pathophys.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T00:32:41Z","timestamp":1366417961000},"page":"131-137","source":"Crossref","is-referenced-by-count":10,"title":["Body weight reduction and metformin: Roles in polycystic ovary syndrome"],"prefix":"10.1016","volume":"20","author":[{"given":"Omar","family":"AL-Nozha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moaz","family":"Mojaddidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Fath","family":"El-Bab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathophys.2013.03.002_bib0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jc.87.2.569","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double-blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0010","first-page":"1059","article-title":"Metformin, an efficacious drug in the treatment of polycystic ovary syndrome","volume":"129","author":"Hahn","year":"2004","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Medicine"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0020","first-page":"173281","article-title":"Relationship between serum lipoprotein ratios and insulin resistance in polycystic ovary syndrome","volume":"2012","author":"Shou-Kui","year":"2012","journal-title":"International Journal of Endocrinology"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pathophys.2013.03.002_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/jwh.2010.2053","article-title":"Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome","volume":"20","author":"Stovall","year":"2011","journal-title":"Journal of Women's Health (Larchmt)"},{"issue":"5","key":"10.1016\/j.pathophys.2013.03.002_bib0035","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2010.03.081","article-title":"Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions","volume":"94","author":"Kristen","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1016\/j.pathophys.2013.03.002_bib0040","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/den182","article-title":"Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?","volume":"23","author":"Moll","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0045","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dei501","article-title":"A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome","volume":"21","author":"Costello","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rigp.2005.04.001","article-title":"Polycystic ovary syndrome: an overview","volume":"5","author":"Bako","year":"2005","journal-title":"Reviews in Gynecology Practice"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11892-002-0061-y","article-title":"Insulin resistance and polycystic ovary syndrome","volume":"2","author":"Ehrmann","year":"2002","journal-title":"Current Diabetes Reports"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/ENDO:30:1:13","article-title":"Insulin resistance in PCOS","volume":"30","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/jc.86.1.66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease","volume":"86","author":"Arslanian","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0075","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2002-021131","article-title":"Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling","volume":"87","author":"Azziz","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/j.pathophys.2013.03.002_bib0080","doi-asserted-by":"crossref","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","article-title":"Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling","volume":"288","author":"Corbould","year":"2005","journal-title":"American Journal of Physiology: Endocrinology and Metabolism"},{"issue":"Suppl. 1","key":"10.1016\/j.pathophys.2013.03.002_bib0085","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.fertnstert.2006.04.011","article-title":"Insulin resistance in women with polycystic ovary syndrome","volume":"86","author":"Dunaif","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1016\/j.pathophys.2013.03.002_bib0090","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","article-title":"Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes","volume":"24","author":"Peppard","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pathophys.2013.03.002_bib0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"PCOS\/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1016\/j.pathophys.2013.03.002_bib0100","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jc.85.1.139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, doubleblind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1016\/j.pathophys.2013.03.002_bib0110","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.fertnstert.2009.01.114","article-title":"Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial","volume":"93","author":"Romualdi","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0120","first-page":"697","article-title":"Current perspectives in polycystic ovary syndrome","volume":"68","author":"Richardson","year":"2003","journal-title":"American Family Physician"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00060793-200208000-00003","article-title":"Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome","volume":"9","author":"Baillargeon","year":"2002","journal-title":"Current Opinion in Endocrinology and Diabetes"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0015-0282(03)00735-0","article-title":"Androgen excess is the key element in polycystic ovary syndrome","volume":"80","author":"Azziz","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0135","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0140","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.286.19.2421","article-title":"Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus","volume":"286","author":"Solomon","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00060793-200212000-00003","article-title":"Diabetes prevalence and risk factors in polycystic ovary syndrome","volume":"9","author":"Legro","year":"2002","journal-title":"Current Opinion in Endocrinology and Diabetes"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0160","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(16)41415-9","article-title":"Plasma testosterone free index: a better indicator of plasma androgen activity?","volume":"26","author":"Clark","year":"1975","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostatic model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pathophys.2013.03.002_bib0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0015-0282(99)00203-4","article-title":"Bone mineral density and body composition in lean women with polycystic ovary syndrome","volume":"72","author":"Good","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1016\/j.pathophys.2013.03.002_bib0175","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1016\/j.pathophys.2013.03.002_bib0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/jc.77.1.80","article-title":"Relationship of body fat percentage and fat distribution with dehydroepiandrosterone sulfate in premenopausal females","volume":"77","author":"Williams","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.pathophys.2013.03.002_bib0185","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0015-0282(16)57419-6","article-title":"Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women","volume":"63","author":"Reubinoff","year":"1995","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-277X.2004.00531.x","article-title":"What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials","volume":"17","author":"Avenell","year":"2004","journal-title":"Journal of Human Nutrition and Dietetics"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0195","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa050156","article-title":"Randomized trial of lifestyle modification and pharmacotherapy for obesity","volume":"353","author":"Wadden","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0200","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"For the UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus","volume":"281","author":"Robert","year":"1999","journal-title":"Journal of the American Medical Association"},{"issue":"5","key":"10.1016\/j.pathophys.2013.03.002_bib0205","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Practice and Research Clinical Obstetrics & Gynaecology"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0215","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells","volume":"76","author":"Attia","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0220","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0225","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study","volume":"89","author":"Orio","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1447-0756.2001.tb01241.x","article-title":"Plasma homocysteine, fasting insulin, and androgen patterns among women with polycystic ovaries and infertility","volume":"27","author":"Sills","year":"2001","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1016\/j.pathophys.2013.03.002_bib0235","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Evanthia","year":"2007","journal-title":"Trends in Endocrinology and Metabolism"}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468013000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468013000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T17:35:41Z","timestamp":1595698541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928468013000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0928468013000047"],"URL":"https:\/\/doi.org\/10.1016\/j.pathophys.2013.03.002","relation":{},"ISSN":["0928-4680"],"issn-type":[{"type":"print","value":"0928-4680"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}